Delivery Order SPE2DB20D2014-SPE2DB25FC54Q
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pioglitazone HCL 30 mg tablets. The contract, valued at $1,186.51, has an ultimate completion date of April 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,136.43 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pioglitazone HCL 45 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency awarded a $1,241.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of pioglitazone hydrochloride 45 mg. The contract has a period of performance from June 27, 2023 through June 28, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, this small order for diabetes medication supports the Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $271,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 mg pioglitazone HCl tablets. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA Troop Support and its customers. Amerisourcebergen will deliver 30-count bottles of the diabetes medication to its facility in Conshohocken, Pennsylvania by September 25,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,255.25 Firm Fixed Price Delivery Order contract is for the supply of Pioglitazone HCL 30 mg Tablets. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- The Defense Logistics Agency awarded a $648 delivery order to Amerisourcebergen Drug Corporation for pioglitazone hydrochloride 30 mg tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30-count bottles of the diabetes medication to a facility in Conshohocken, Pennsylvania between September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for pioglitazone tablets supports the Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-one dollars and forty-two cents to Amerisourcebergen Drug Corporation for pioglitazone hydrochloride 45 mg tablets. Under the contract, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required from July 17 through July 18, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,073,674 tablets of Pioglitazone HCL 45 mg. The order has a ceiling value of $1,111.78 and a period of performance through March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and running through December 31, 2025, which...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 4,564,135,046 units of the pharmaceutical product Pioglitazone HCL 30 mg tablets. The award is valued at $3,561.31 and has a period of performance through April 2, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC54QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,504.46 to AmerisourceBergen Drug Corp for 500 tablets of Pioglitazone HCL 30 mg, a diabetes management medication. The contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, is structured as a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support to military healthcare programs, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The arrangement allows AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with the company's competitive award history demonstrating its capability to fulfill federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/23/25 |